Does the media refer more to ADGM or CTSO?

In the previous week, Cytosorbents had 2 more articles in the media than Adagio Medical. MarketBeat recorded 3 mentions for Cytosorbents and 1 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 0.00 equaled Cytosorbents'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adagio Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cytosorbents 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate ADGM or TMDIF?

Adagio Medical currently has a consensus target price of $3.50, indicating a potential upside of 2,380.51%. Given Adagio Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Adagio Medical is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is ADGM or TMDIF more profitable?

Titan Medical's return on equity of -82.31% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets Adagio Medical N/A -661.85% -73.35% Titan Medical N/A -82.31% -51.47%

Which has stronger earnings & valuation, IRIX or ADGM?

IRIDEX has higher revenue and earnings than Adagio Medical. IRIDEX is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.23 -$4.44M -$0.20 N/A Adagio Medical $600K 5.22 -$25.08M -$1.48 N/A

Is IRIX or ADGM more profitable?

Adagio Medical has a net margin of 0.00% compared to IRIDEX's net margin of -6.88%. IRIDEX's return on equity of 0.00% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.88% N/A -12.55% Adagio Medical N/A -661.85% -73.35%

Does the media prefer IRIX or ADGM?

In the previous week, IRIDEX had 2 more articles in the media than Adagio Medical. MarketBeat recorded 3 mentions for IRIDEX and 1 mentions for Adagio Medical. IRIDEX's average media sentiment score of 0.00 equaled Adagio Medical'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IRIDEX 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Adagio Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer NMTC or ADGM?

In the previous week, NeuroOne Medical Technologies had 7 more articles in the media than Adagio Medical. MarketBeat recorded 8 mentions for NeuroOne Medical Technologies and 1 mentions for Adagio Medical. NeuroOne Medical Technologies' average media sentiment score of 0.72 beat Adagio Medical's score of 0.00 indicating that NeuroOne Medical Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeuroOne Medical Technologies 2 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Adagio Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor SINT or ADGM?

In the previous week, Sintx Technologies had 9 more articles in the media than Adagio Medical. MarketBeat recorded 10 mentions for Sintx Technologies and 1 mentions for Adagio Medical. Sintx Technologies' average media sentiment score of 0.21 beat Adagio Medical's score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sintx Technologies 1 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Adagio Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Adagio Medical (ADGM) Competitors

$0.14 0.00 (-2.20%)

Closing price 04:00 PM Eastern

Extended Trading

$0.14 +0.00 (+2.17%)

As of 07:58 PM Eastern

Compare

ADGM vs. CTSO, TMDIF, IRIX, NMTC, and SINT

Should you buy Adagio Medical stock or one of its competitors? Adagio Medical's main competitors and comparable companies include Cytosorbents (CTSO), Titan Medical (TMDIF), IRIDEX (IRIX), NeuroOne Medical Technologies (NMTC), and Sintx Technologies (SINT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Adagio Medical compare to Cytosorbents?

Adagio Medical (NASDAQ:ADGM) and Cytosorbents (NASDAQ:CTSO) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.

Adagio Medical currently has a consensus target price of $3.50, indicating a potential upside of 2,380.51%. Cytosorbents has a consensus target price of $107.50, indicating a potential upside of 2,614.65%. Given Cytosorbents' higher probable upside, analysts clearly believe Cytosorbents is more favorable than Adagio Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Cytosorbents	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 32.9% of Cytosorbents shares are owned by institutional investors. 7.8% of Adagio Medical shares are owned by company insiders. Comparatively, 7.8% of Cytosorbents shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Adagio Medical has a beta of 0.01, meaning that its stock price is 99% less volatile than the broader market. Comparatively, Cytosorbents has a beta of 1.37, meaning that its stock price is 37% more volatile than the broader market.

In the previous week, Cytosorbents had 2 more articles in the media than Adagio Medical. MarketBeat recorded 3 mentions for Cytosorbents and 1 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 0.00 equaled Cytosorbents'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adagio Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cytosorbents	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Adagio Medical has a net margin of 0.00% compared to Cytosorbents' net margin of -48.94%. Cytosorbents' return on equity of -431.65% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-661.85%	-73.35%
Cytosorbents	-48.94%	-431.65%	-41.94%

Cytosorbents has higher revenue and earnings than Adagio Medical. Cytosorbents is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	$600K	5.22	-$25.08M	-$1.48	N/A
Cytosorbents	$37.06M	0.34	-$8.20M	-$5.80	N/A

Summary

Adagio Medical beats Cytosorbents on 8 of the 15 factors compared between the two stocks.

How does Adagio Medical compare to Titan Medical?

Adagio Medical (NASDAQ:ADGM) and Titan Medical (NASDAQ:TMDIF) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

In the previous week, Adagio Medical had 1 more articles in the media than Titan Medical. MarketBeat recorded 1 mentions for Adagio Medical and 0 mentions for Titan Medical. Adagio Medical's average media sentiment score of 0.00 equaled Titan Medical'saverage media sentiment score.

Company	Overall Sentiment
Adagio Medical	Neutral
Titan Medical	Neutral

Titan Medical has higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	$600K	5.22	-$25.08M	-$1.48	N/A
Titan Medical	$17.63M	0.71	$6.95M	$0.05	2.20

Titan Medical's return on equity of -82.31% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-661.85%	-73.35%
Titan Medical	N/A	-82.31%	-51.47%

Adagio Medical currently has a consensus target price of $3.50, indicating a potential upside of 2,380.51%. Given Adagio Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Adagio Medical is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Adagio Medical has a beta of 0.01, indicating that its share price is 99% less volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 7.8% of Adagio Medical shares are owned by company insiders. Comparatively, 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Adagio Medical and Titan Medical tied by winning 7 of the 14 factors compared between the two stocks.

How does Adagio Medical compare to IRIDEX?

IRIDEX (NASDAQ:IRIX) and Adagio Medical (NASDAQ:ADGM) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

IRIDEX has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market. Comparatively, Adagio Medical has a beta of 0.01, meaning that its share price is 99% less volatile than the broader market.

IRIDEX currently has a consensus price target of $3.00, indicating a potential upside of 334.78%. Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 2,380.51%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts plainly believe Adagio Medical is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 8.6% of IRIDEX shares are held by company insiders. Comparatively, 7.8% of Adagio Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, IRIDEX had 2 more articles in the media than Adagio Medical. MarketBeat recorded 3 mentions for IRIDEX and 1 mentions for Adagio Medical. IRIDEX's average media sentiment score of 0.00 equaled Adagio Medical'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IRIDEX	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Adagio Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

IRIDEX has higher revenue and earnings than Adagio Medical. IRIDEX is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.23	-$4.44M	-$0.20	N/A
Adagio Medical	$600K	5.22	-$25.08M	-$1.48	N/A

Adagio Medical has a net margin of 0.00% compared to IRIDEX's net margin of -6.88%. IRIDEX's return on equity of 0.00% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.88%	N/A	-12.55%
Adagio Medical	N/A	-661.85%	-73.35%

Summary

IRIDEX beats Adagio Medical on 8 of the 15 factors compared between the two stocks.

How does Adagio Medical compare to NeuroOne Medical Technologies?

NeuroOne Medical Technologies (NASDAQ:NMTC) and Adagio Medical (NASDAQ:ADGM) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

In the previous week, NeuroOne Medical Technologies had 7 more articles in the media than Adagio Medical. MarketBeat recorded 8 mentions for NeuroOne Medical Technologies and 1 mentions for Adagio Medical. NeuroOne Medical Technologies' average media sentiment score of 0.72 beat Adagio Medical's score of 0.00 indicating that NeuroOne Medical Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeuroOne Medical Technologies	2 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Adagio Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 11.8% of NeuroOne Medical Technologies shares are held by insiders. Comparatively, 7.8% of Adagio Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

NeuroOne Medical Technologies has higher revenue and earnings than Adagio Medical. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroOne Medical Technologies	$9.47M	1.07	-$3.61M	-$0.95	N/A
Adagio Medical	$600K	5.22	-$25.08M	-$1.48	N/A

Adagio Medical has a net margin of 0.00% compared to NeuroOne Medical Technologies' net margin of -71.50%. NeuroOne Medical Technologies' return on equity of -128.12% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroOne Medical Technologies	-71.50%	-128.12%	-86.34%
Adagio Medical	N/A	-661.85%	-73.35%

NeuroOne Medical Technologies has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market. Comparatively, Adagio Medical has a beta of 0.01, meaning that its share price is 99% less volatile than the broader market.

NeuroOne Medical Technologies presently has a consensus target price of $7.33, indicating a potential upside of 557.70%. Adagio Medical has a consensus target price of $3.50, indicating a potential upside of 2,380.51%. Given Adagio Medical's higher probable upside, analysts clearly believe Adagio Medical is more favorable than NeuroOne Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

NeuroOne Medical Technologies beats Adagio Medical on 10 of the 16 factors compared between the two stocks.

How does Adagio Medical compare to Sintx Technologies?

Sintx Technologies (NASDAQ:SINT) and Adagio Medical (NASDAQ:ADGM) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

In the previous week, Sintx Technologies had 9 more articles in the media than Adagio Medical. MarketBeat recorded 10 mentions for Sintx Technologies and 1 mentions for Adagio Medical. Sintx Technologies' average media sentiment score of 0.21 beat Adagio Medical's score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sintx Technologies	1 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Adagio Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Sintx Technologies currently has a consensus price target of $9.50, indicating a potential upside of 335.78%. Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 2,380.51%. Given Adagio Medical's higher probable upside, analysts clearly believe Adagio Medical is more favorable than Sintx Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Sintx Technologies has higher revenue and earnings than Adagio Medical. Sintx Technologies is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$1.02M	9.23	-$10.36M	-$4.91	N/A
Adagio Medical	$600K	5.22	-$25.08M	-$1.48	N/A

Adagio Medical has a net margin of 0.00% compared to Sintx Technologies' net margin of -848.20%. Sintx Technologies' return on equity of -354.44% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-848.20%	-354.44%	-115.37%
Adagio Medical	N/A	-661.85%	-73.35%

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Comparatively, 7.8% of Adagio Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Sintx Technologies beats Adagio Medical on 8 of the 15 factors compared between the two stocks.

Get Adagio Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ADGM vs. The Competition

Export

Metric	Adagio Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.13M	$5.56B	$7.19B	$13.39B
Dividend Yield	N/A	1.78%	2.53%	18.16%
P/E Ratio	-0.09	21.03	204.51	20.70
Price / Sales	5.11	69.13	582.81	90.24
Price / Cash	N/A	32.45	79.41	53.24
Price / Book	0.23	5.97	11.04	6.33
Net Income	-$25.08M	$146.97M	$3.49B	$381.26M
7 Day Performance	-4.17%	-0.73%	-2.30%	-0.61%
1 Month Performance	-75.53%	-4.79%	-7.05%	-4.84%
1 Year Performance	-93.30%	1.14%	5.64%	1.12%

Adagio Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ADGM Adagio Medical	1.9133 of 5 stars	$0.14 -2.2%	$3.50 +2,436.2%	-92.9%	$3.13M	$600K	N/A	41	Gap Down
CTSO Cytosorbents	3.2115 of 5 stars	$3.97 -0.9%	$107.50 +2,611.2%	-79.9%	$12.49M	$37.06M	N/A	129	Gap Up
TMDIF Titan Medical	N/A	$0.11 -3.3%	N/A	-77.1%	$12.18M	$17.63M	N/A	50	Gap Down
IRIX IRIDEX	1.5864 of 5 stars	$0.63 -0.8%	$3.00 +376.2%	-42.5%	$11.07M	$52.67M	N/A	108	News Coverage Gap Up
NMTC NeuroOne Medical Technologies	3.9458 of 5 stars	$1.09 -0.5%	$7.33 +575.9%	-80.0%	$9.88M	$9.47M	N/A	18	News Coverage Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ADGM) was last updated on 10/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Adagio Medical (ADGM) Competitors

ADGM vs. CTSO, TMDIF, IRIX, NMTC, and SINT

How does Adagio Medical compare to Cytosorbents?

Summary

How does Adagio Medical compare to Titan Medical?

Summary

How does Adagio Medical compare to IRIDEX?

Summary

How does Adagio Medical compare to NeuroOne Medical Technologies?

Summary

How does Adagio Medical compare to Sintx Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADGM vs. The Competition

Adagio Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Adagio Medical (ADGM) Competitors

ADGM vs. CTSO, TMDIF, IRIX, NMTC, and SINT

How does Adagio Medical compare to Cytosorbents?

Do analysts recommend ADGM or CTSO?

Do insiders and institutionals believe in ADGM or CTSO?

Which has more volatility & risk, ADGM or CTSO?

Does the media refer more to ADGM or CTSO?

Is ADGM or CTSO more profitable?

Which has higher earnings and valuation, ADGM or CTSO?

Summary

How does Adagio Medical compare to Titan Medical?

Does the media refer more to ADGM or TMDIF?

Which has higher earnings & valuation, ADGM or TMDIF?

Is ADGM or TMDIF more profitable?

Do analysts rate ADGM or TMDIF?

Which has more volatility & risk, ADGM or TMDIF?

Do insiders & institutionals hold more shares of ADGM or TMDIF?

Summary

How does Adagio Medical compare to IRIDEX?

Which has more risk & volatility, IRIX or ADGM?

Do analysts prefer IRIX or ADGM?

Do institutionals and insiders believe in IRIX or ADGM?

Does the media prefer IRIX or ADGM?

Which has stronger earnings & valuation, IRIX or ADGM?

Is IRIX or ADGM more profitable?

Summary

How does Adagio Medical compare to NeuroOne Medical Technologies?

Does the media prefer NMTC or ADGM?

Do institutionals & insiders believe in NMTC or ADGM?

Which has better valuation & earnings, NMTC or ADGM?

Is NMTC or ADGM more profitable?

Which has more volatility & risk, NMTC or ADGM?

Do analysts prefer NMTC or ADGM?

Summary

How does Adagio Medical compare to Sintx Technologies?

Does the media favor SINT or ADGM?

Do analysts recommend SINT or ADGM?

Which has better earnings & valuation, SINT or ADGM?

Is SINT or ADGM more profitable?

Do insiders & institutionals believe in SINT or ADGM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADGM vs. The Competition

Adagio Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools